Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer

Inflammatory Bowel Diseases

Volumn 16, Issue 3, 2010, Pages 474-481

  Brackmann, Stephan ^a   Aamodt, Geir ^a   Andersen, Solveig Norheim ^a   Roald, Borghild ^a   Langmark, Frøydis ^b   Clausen, Ole P F ^c   Aadland, Erling ^d   Fausa, Olav ^c   Rydning, Andreas ^a   Vatn, Morten H ^a,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Colorectal neoplasm; Crohn's disease; Inflammatory bowel diseases; Survival; Ulcerative colitis

Indexed keywords

MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; ENTERITIS; FEMALE; GASTROINTESTINAL DYSPLASIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADULT; AGE DISTRIBUTION; AGED; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; NORWAY; PROGNOSIS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77149163541     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21053     Document Type: Article

References (20)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535.
2. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724-2729.
3. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323: 1228-1233.
4. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990; 336:357-359.
5. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
6. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099-1105; quiz 1340-1341.
7. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356-1362.
8. Brentnall TA, Haggitt RC, Rabinovitch PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996;110:331-338.
9. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut. 1997;41:522-525.
10. van Staa TP, Card T, Logan RF, et al. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. 2005;54:1573-1578.
11. Gyde SN, Prior P, Thompson H, et al. Survival of patients with colorectal cancer complicating ulcerative colitis. Gut. 1984;25:228-231.
12. Delaunoit T, Limburg PJ, Goldberg RM, et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335-342.
13. van Heerden JA, Beart RW Jr. Carcinoma of the colon and rectum complicating chronic ulcerative colitis. Dis Colon Rectum. 1980;23: 155-159.
14. Jensen AB, Larsen M, Gislum M, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol. 2006;101:1283-1287.
15. Larsen M, Mose H, Gislum M, et al. Survival after colorectal cancer in patients with Crohn's disease: a nationwide population-based Danish follow-up study. Am J Gastroenterol. 2007;102:163-167.
16. Brackmann SA, Andersen SN, Aamodt G, et al. Two distinct groups of colorectal cancer in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:9-16.
17. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum. 1985;28:383-388.
18. Taylor BA, Pemberton JH, Carpenter HA, et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum. 1992;35:950-956.
19. Connell WR, Talbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994;35:1419-1423.
20. Lutgens MW. Colonoscopic surveillance in inflammatory bowel disease improves survival after colorectal cancer diagnosis. Gastroenterology. 2008;134:A-35.